Cargando…
Mifepristone versus placebo to treat uterine myoma: a double-blind, randomized clinical trial
OBJECTIVE: To evaluate the efficacy, safety, and quality of life of 5 mg mifepristone per day compared with a placebo in treating uterine fibroids. DESIGN: Randomized, double-blind clinical study. LOCATION: Eusebio Hernández Gynecology and Obstetrics Teaching Hospital, Havana, Cuba. SUBJECTS: One hu...
Autores principales: | Esteve, Josep Lluis Carbonell, Acosta, Rita, Pérez, Yasmirian, Rodriguez, Barbara, Seigler, Isabel, Sanchez, Carlos, Tomasi, Giuseppe |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dove Medical Press
2013
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3702243/ https://www.ncbi.nlm.nih.gov/pubmed/23843709 http://dx.doi.org/10.2147/IJWH.S42770 |
Ejemplares similares
-
Treatment of Uterine Myoma with 2.5 or 5 mg Mifepristone Daily during 3 Months with 9 Months Posttreatment Followup: Randomized Clinical Trial
por: Carbonell, Josep Lluis, et al.
Publicado: (2013) -
Safety and effectiveness of different dosage of mifepristone for the treatment of uterine fibroids: a double-blind randomized clinical trial
por: Carbonell, Josep LL, et al.
Publicado: (2013) -
Mifepristone 5 mg versus 10 mg for emergency contraception: double-blind randomized clinical trial
por: Carbonell, Josep Lluis, et al.
Publicado: (2015) -
Effect of mifepristone (25 mg) in treatment of uterine myoma in perimenopausal woman
por: Seth, Shikha, et al.
Publicado: (2013) -
Mifepristone 2.5 mg versus 5 mg daily in the treatment of leiomyoma before surgery
por: Carbonell Esteve, Josep L, et al.
Publicado: (2012)